Dasatinib Tablet is a targeted cancer therapy used in the treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). Dasatinib Tablet works by blocking specific proteins that drive the growth of cancer cells, helping to control the disease effectively.
With its advanced mechanism, it offers a powerful option for long-term cancer management under specialist supervision.
